<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05073978</url>
  </required_header>
  <id_info>
    <org_study_id>20210119SHJ001</org_study_id>
    <nct_id>NCT05073978</nct_id>
  </id_info>
  <brief_title>B-vitamin Levels and Adverse Pregnancy Outcomes</brief_title>
  <official_title>The Association Between Niacin Deficiency and Birth Defects: a Case-control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Westlake University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Obstetrics and Gynecology Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Westlake University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective case-control study aims to examine the effects of blood vitamin B levels in&#xD;
      first-trimester pregnant women on the pregnancy outcomes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Folate deficiency can cause severe adverse pregnancy outcomes, such as neural tube defects.&#xD;
      Effective folate functioning requires essential metabolic interactions with other B vitamins&#xD;
      including vitamin B2, vitamin B3, vitamin B6, and vitamin B12, which can also influence&#xD;
      pregnancy outcomes independently. For example, animal and family studies have identified that&#xD;
      niacin (B3) deficiency can lead to congenital malformations. However, how folate and related&#xD;
      B-vitamin levels interact with each other while affecting various pregnancy outcomes&#xD;
      including abortion, birth defects, pregnancy complications, etc. is unclear. Besides, folate&#xD;
      levels in previous studies were mostly measured in plasma which are easily influenced by&#xD;
      dietary factors, instead of red blood cell folate which can reflect the long-term status.&#xD;
      Moreover, the difference in the risk of neural tube defects across a range of maternal red&#xD;
      blood cell folate concentrations has been largely ignored. Using data of pregnant women&#xD;
      recruited at Beijing Obstetrics and Gynecology Hospital from December 2020 to December 2021,&#xD;
      this case-control study aims to examine the association of folate and related B-vitamin&#xD;
      levels in first-trimester blood samples (plasma and red blood cell) with pregnancy outcomes,&#xD;
      particularly the association between niacin deficiency and birth defects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fetal outcomes</measure>
    <time_frame>at delivery</time_frame>
    <description>Including intrauterine growth retardation,abortion, stillbirth, preterm birth, live birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fetal outcomes</measure>
    <time_frame>42 days after delivery</time_frame>
    <description>Including birth defects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>maternal outcomes</measure>
    <time_frame>at delivery</time_frame>
    <description>Including gestational hypertension, preeclampsia, gestational diabetes mellitus, hypothyroidism</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Birth Defect</condition>
  <condition>Pregnancy Loss</condition>
  <condition>Pregnancy Complications</condition>
  <condition>Pregnancy Induced Hypertension</condition>
  <condition>Recurrent Pregnancy Loss</condition>
  <condition>Health Problems in Pregnancy</condition>
  <condition>Gestational Diabetes</condition>
  <condition>Gestational Hypertension</condition>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Case group</arm_group_label>
    <description>Case group with certain pregnancy outcome, e.g., abortion, stillbirth, preterm birth, and birth defects,gestational hypertension, gestational diabetes mellitus, etc.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Control group without certain pregnancy outcome,e.g., abortion, stillbirth, preterm birth, and birth defects,gestational hypertension, gestational diabetes mellitus, etc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>This is an observational study without any intervention</description>
    <arm_group_label>Case group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      first-trimester maternal blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        all pregnant women recruited in the birth cohort of Beijing Obstetrics and Gynecology&#xD;
        Hospital between 2020.12 to 2021.12&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women with 6-13(+6 days) gestational weeks&#xD;
&#xD;
          -  Resided in Beijing in the past year&#xD;
&#xD;
          -  Pregnant women who intend to have antenatal examinations and delivery at Beijing&#xD;
             Obstetrics and Gynecology Hospital&#xD;
&#xD;
          -  Pregnant women who are willing to participate in this study with informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with Hepatitis B, syphilis, HIV/AIDS and other infectious diseases.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hongjun Shi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Westlake University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongjun Shi, PhD</last_name>
    <phone>86-0571-85271192</phone>
    <email>shihongjun@westlake.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Danyang Wang, Master</last_name>
    <email>wangdanyang@westlake.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Obstetrics and Gynecology Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongjun SHI, PhD</last_name>
      <phone>86-0571-85271192</phone>
      <email>shihongjun@westlake.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Hongjun Shi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin B</keyword>
  <keyword>pregnancy outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Fetal Death</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

